Bellevue Group AG Sells 66,611 Shares of Privia Health Group, Inc. $PRVA

Bellevue Group AG reduced its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 9.6% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 630,697 shares of the company’s stock after selling 66,611 shares during the period. Bellevue Group AG’s holdings in Privia Health Group were worth $14,506,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the business. Advantage Alpha Capital Partners LP bought a new position in Privia Health Group during the 2nd quarter valued at approximately $3,941,000. Hsbc Holdings PLC increased its stake in shares of Privia Health Group by 69.2% during the second quarter. Hsbc Holdings PLC now owns 113,718 shares of the company’s stock valued at $2,549,000 after buying an additional 46,526 shares during the period. Strs Ohio bought a new position in shares of Privia Health Group during the first quarter valued at approximately $849,000. Edgestream Partners L.P. bought a new position in shares of Privia Health Group during the second quarter valued at approximately $2,209,000. Finally, State of Alaska Department of Revenue lifted its stake in Privia Health Group by 9.1% in the second quarter. State of Alaska Department of Revenue now owns 62,406 shares of the company’s stock worth $1,435,000 after acquiring an additional 5,223 shares during the period. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $24.91 on Friday. The business has a fifty day moving average price of $24.44 and a 200-day moving average price of $22.79. The company has a market capitalization of $3.06 billion, a PE ratio of 191.63, a PEG ratio of 4.28 and a beta of 0.83. Privia Health Group, Inc. has a 1-year low of $18.77 and a 1-year high of $26.51.

Privia Health Group (NASDAQ:PRVA) last announced its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million for the quarter. Privia Health Group had a net margin of 0.89% and a return on equity of 2.52%. On average, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have issued reports on PRVA. JMP Securities boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “market outperform” rating in a research report on Friday, August 29th. Evercore ISI lifted their target price on shares of Privia Health Group from $28.00 to $30.00 and gave the company an “outperform” rating in a research note on Friday, November 7th. Canaccord Genuity Group increased their price target on shares of Privia Health Group from $32.00 to $34.00 and gave the stock a “buy” rating in a research note on Wednesday, November 12th. Truist Financial restated a “buy” rating and issued a $31.00 price objective (up from $30.00) on shares of Privia Health Group in a report on Monday, November 10th. Finally, BMO Capital Markets started coverage on Privia Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $30.00 target price on the stock. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $30.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.